The interplay between mitochondrial DNA genotypes, female infertility, ovarian response, and mutagenesis in oocytes.

IF 8.3 Q1 OBSTETRICS & GYNECOLOGY Human reproduction open Pub Date : 2024-12-30 eCollection Date: 2025-01-01 DOI:10.1093/hropen/hoae074
Annelore Van Der Kelen, Letizia Li Piani, Joke Mertens, Marius Regin, Edouard Couvreu de Deckersberg, Hilde Van de Velde, Karen Sermon, Herman Tournaye, Willem Verpoest, Frederik Jan Hes, Christophe Blockeel, Claudia Spits
{"title":"The interplay between mitochondrial DNA genotypes, female infertility, ovarian response, and mutagenesis in oocytes.","authors":"Annelore Van Der Kelen, Letizia Li Piani, Joke Mertens, Marius Regin, Edouard Couvreu de Deckersberg, Hilde Van de Velde, Karen Sermon, Herman Tournaye, Willem Verpoest, Frederik Jan Hes, Christophe Blockeel, Claudia Spits","doi":"10.1093/hropen/hoae074","DOIUrl":null,"url":null,"abstract":"<p><strong>Study question: </strong>Is there an association between different mitochondrial DNA (mtDNA) genotypes and female infertility or ovarian response, and is the appearance of variants in the oocytes favored by medically assisted reproduction (MAR) techniques?</p><p><strong>Summary answer: </strong>Ovarian response was negatively associated with global non-synonymous protein-coding homoplasmic variants but positively associated with haplogroup K; the number of oocytes retrieved in a cycle correlates with the number of heteroplasmic variants in the oocytes, principally with variants located in the hypervariable (HV) region and rRNA loci, as well as non-synonymous protein-coding variants.</p><p><strong>What is known already: </strong>Several genes have been shown to be positively associated with infertility, and there is growing concern that MAR may facilitate the transmission of these harmful variants to offspring, thereby passing on infertility. The potential role of mtDNA variants in these two perspectives remains poorly understood.</p><p><strong>Study design size duration: </strong>This cohort study included 261 oocytes from 132 women (mean age: 32 ± 4 years) undergoing ovarian stimulation between 2019 and 2020 at an academic center. The oocyte mtDNA genotypes were examined for associations with the women's fertility characteristics.</p><p><strong>Participants/materials setting methods: </strong>The mtDNA of the oocytes underwent deep sequencing, and the mtDNA genotypes were compared between infertile and fertile groups using Fisher's exact test. The impact of the mtDNA genotype on anti-Müllerian hormone (AMH) levels and the number of (mature) oocytes retrieved was assessed using the Mann-Whitney <i>U</i> test for univariate analysis and logistic regression for multivariate analysis. Additionally, we examined the associations of oocyte maturation stage, infertility status, number of ovarian stimulation units, and number of oocytes retrieved with the type and load of heteroplasmic variants using univariate analysis and Poisson or linear regression analysis.</p><p><strong>Main results and the role of chance: </strong>Neither homoplasmic mtDNA variants nor haplogroups in the oocytes were associated with infertility status or with AMH levels. Conversely, when the relationship between the number of oocytes retrieved and different mtDNA genotypes was examined, a positive association was observed between the number of metaphase (MII) oocytes (<i>P</i> = 0.005) and haplogroup K. Furthermore, the presence of global non-synonymous homoplasmic variants in the protein-coding region was significantly associated with a reduced number of total oocytes and MII oocytes retrieved (<i>P</i> < 0.001 for both). Regarding the type and load of heteroplasmic variants in the different regions, there were no significant associations according to maturation stage of the oocyte or to fertility status; however, the number of oocytes retrieved correlated positively with the total number of heteroplasmic variants, and specifically with non-synonymous protein-coding, HV and rRNA variants (<i>P</i> < 0.001 for all).</p><p><strong>Limitations reasons for caution: </strong>The current work is constrained by its retrospective design and single-center approach, potentially limiting the generalizability of our findings. The small sample size for specific types of infertility restricts this aspect of the findings.</p><p><strong>Wider implications of the findings: </strong>This work suggests that mitochondrial genetics may have an impact on ovarian response and corroborates previous findings indicating that the size of the oocyte cohort after stimulation correlates with the presence of potentially deleterious variants in the oocyte. Future epidemiological and functional studies based on the results of the current study will provide valuable insights to address gaps in knowledge to assess any prospective risks for MAR-conceived offspring.</p><p><strong>Study funding/competing interests: </strong>This work was supported by the Research Foundation Flanders (FWO, Grant numbers 1506617N and 1506717N to C.S.), by the Fonds Wetenschappelijk Fonds, Willy Gepts Research Foundation of Universitair Ziekenhuis Brussel (Grant numbers WFWG14-15, WFWG16-43, and WFWG19-19 to C.S.), and by the Methusalem Grant of the Vrije Universiteit Brussel (to K.S.). M.R. and E.C.d.D. were supported predoctoral fellowships by the FWO, Grant numbers 1133622N and 1S73521N, respectively. The authors declare no conflict of interests.</p><p><strong>Trial registration number: </strong>N/A.</p>","PeriodicalId":73264,"journal":{"name":"Human reproduction open","volume":"2025 1","pages":"hoae074"},"PeriodicalIF":8.3000,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739621/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human reproduction open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/hropen/hoae074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Study question: Is there an association between different mitochondrial DNA (mtDNA) genotypes and female infertility or ovarian response, and is the appearance of variants in the oocytes favored by medically assisted reproduction (MAR) techniques?

Summary answer: Ovarian response was negatively associated with global non-synonymous protein-coding homoplasmic variants but positively associated with haplogroup K; the number of oocytes retrieved in a cycle correlates with the number of heteroplasmic variants in the oocytes, principally with variants located in the hypervariable (HV) region and rRNA loci, as well as non-synonymous protein-coding variants.

What is known already: Several genes have been shown to be positively associated with infertility, and there is growing concern that MAR may facilitate the transmission of these harmful variants to offspring, thereby passing on infertility. The potential role of mtDNA variants in these two perspectives remains poorly understood.

Study design size duration: This cohort study included 261 oocytes from 132 women (mean age: 32 ± 4 years) undergoing ovarian stimulation between 2019 and 2020 at an academic center. The oocyte mtDNA genotypes were examined for associations with the women's fertility characteristics.

Participants/materials setting methods: The mtDNA of the oocytes underwent deep sequencing, and the mtDNA genotypes were compared between infertile and fertile groups using Fisher's exact test. The impact of the mtDNA genotype on anti-Müllerian hormone (AMH) levels and the number of (mature) oocytes retrieved was assessed using the Mann-Whitney U test for univariate analysis and logistic regression for multivariate analysis. Additionally, we examined the associations of oocyte maturation stage, infertility status, number of ovarian stimulation units, and number of oocytes retrieved with the type and load of heteroplasmic variants using univariate analysis and Poisson or linear regression analysis.

Main results and the role of chance: Neither homoplasmic mtDNA variants nor haplogroups in the oocytes were associated with infertility status or with AMH levels. Conversely, when the relationship between the number of oocytes retrieved and different mtDNA genotypes was examined, a positive association was observed between the number of metaphase (MII) oocytes (P = 0.005) and haplogroup K. Furthermore, the presence of global non-synonymous homoplasmic variants in the protein-coding region was significantly associated with a reduced number of total oocytes and MII oocytes retrieved (P < 0.001 for both). Regarding the type and load of heteroplasmic variants in the different regions, there were no significant associations according to maturation stage of the oocyte or to fertility status; however, the number of oocytes retrieved correlated positively with the total number of heteroplasmic variants, and specifically with non-synonymous protein-coding, HV and rRNA variants (P < 0.001 for all).

Limitations reasons for caution: The current work is constrained by its retrospective design and single-center approach, potentially limiting the generalizability of our findings. The small sample size for specific types of infertility restricts this aspect of the findings.

Wider implications of the findings: This work suggests that mitochondrial genetics may have an impact on ovarian response and corroborates previous findings indicating that the size of the oocyte cohort after stimulation correlates with the presence of potentially deleterious variants in the oocyte. Future epidemiological and functional studies based on the results of the current study will provide valuable insights to address gaps in knowledge to assess any prospective risks for MAR-conceived offspring.

Study funding/competing interests: This work was supported by the Research Foundation Flanders (FWO, Grant numbers 1506617N and 1506717N to C.S.), by the Fonds Wetenschappelijk Fonds, Willy Gepts Research Foundation of Universitair Ziekenhuis Brussel (Grant numbers WFWG14-15, WFWG16-43, and WFWG19-19 to C.S.), and by the Methusalem Grant of the Vrije Universiteit Brussel (to K.S.). M.R. and E.C.d.D. were supported predoctoral fellowships by the FWO, Grant numbers 1133622N and 1S73521N, respectively. The authors declare no conflict of interests.

Trial registration number: N/A.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
线粒体DNA基因型、女性不育、卵巢反应和卵母细胞突变之间的相互作用。
研究问题:不同的线粒体DNA (mtDNA)基因型与女性不孕症或卵巢反应之间是否存在关联,以及医学辅助生殖(MAR)技术所青睐的卵母细胞变异的出现?总结答案:卵巢反应与全局非同义蛋白编码同质变异负相关,但与单倍群K正相关;在一个周期中获得的卵母细胞的数量与卵母细胞中的异质变异的数量相关,主要是位于高变区和rRNA位点的变异,以及非同义的蛋白质编码变异。已知情况:一些基因已被证明与不孕症呈正相关,人们越来越担心MAR可能会促进这些有害变异向后代的传播,从而传递不孕症。mtDNA变异在这两个方面的潜在作用仍然知之甚少。研究设计规模持续时间:该队列研究包括来自132名女性(平均年龄:32±4岁)的261个卵母细胞,这些女性于2019年至2020年在一个学术中心接受卵巢刺激。研究了卵母细胞mtDNA基因型与妇女生育特征的关系。参与者/材料设置方法:对卵母细胞mtDNA进行深度测序,采用Fisher精确检验比较不育组和可育组的mtDNA基因型。mtDNA基因型对抗勒氏激素(AMH)水平和(成熟)卵母细胞数量的影响采用单因素分析的Mann-Whitney U检验和多因素分析的logistic回归进行评估。此外,我们使用单变量分析和泊松或线性回归分析,研究了卵母细胞成熟阶段、不孕状态、卵巢刺激单位数量和卵母细胞数量与异质变异的类型和负荷之间的关系。主要结果和偶然性的作用:卵母细胞的同质mtDNA变异和单倍群都与不育状态或AMH水平无关。相反,当检测到卵母细胞数量与不同mtDNA基因型之间的关系时,发现中期(MII)卵母细胞数量(P = 0.005)与k单倍群呈正相关(P = 0.005)。此外,蛋白质编码区存在全局非同义同质变异与总卵母细胞数量和MII卵母细胞数量的减少显著相关(P P)。目前的工作受到其回顾性设计和单中心方法的限制,可能限制了我们研究结果的普遍性。特定类型不孕症的小样本量限制了这方面的研究结果。研究结果的更广泛意义:这项工作表明线粒体遗传学可能对卵巢反应有影响,并证实了先前的研究结果,即刺激后卵母细胞队列的大小与卵母细胞中潜在有害变异的存在相关。基于当前研究结果的未来流行病学和功能研究将为解决知识空白提供有价值的见解,以评估mar受孕后代的任何潜在风险。研究经费/竞争利益:这项工作得到了弗兰德斯研究基金会(FWO,资助号1506617N和1506717N到C.S.)、Wetenschappelijk基金会、布鲁塞尔大学Ziekenhuis Willy Gepts研究基金会(资助号WFWG14-15、WFWG16-43和WFWG19-19到C.S.)和布鲁塞尔自由大学Methusalem资助(给K.S.)的支持。M.R.和E.C.d.D.分别获得了两个组织的博士前奖学金,资助号分别为1133622N和1S73521N。作者声明没有利益冲突。试验注册号:无。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.50
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase). The interplay between mitochondrial DNA genotypes, female infertility, ovarian response, and mutagenesis in oocytes. Unmasking the risk: clinical trials versus real-world evidence on dydrogesterone and birth defects. Evidence-based guideline: premature ovarian insufficiency. Independent factors associated with intracytoplasmic sperm injection outcomes in patients with complete azoospermia factor c microdeletions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1